[Enzastaurin is a PKC β inhibitor and is in clinical trials for lymphomas, gliomas, and lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE